Clinic for Radiotherapy and Radiation Oncology, Ruppiner Kliniken GmbH, University Hospital of the Medizinische Hochschule Theodor Fontane Brandenburg, Neuruppin, Germany.
Institute of Radiation Oncology, Cantonal Hospital Winterthur (KSW), Brauerstrasse 15, 8401 Winterthur, Switzerland.
Br J Radiol. 2022 Jul 1;95(1135):20210295. doi: 10.1259/bjr.20210295. Epub 2021 Jun 23.
To prospectively analyze the feasibility of an algorithm for patient preparation, treatment planning, and selection for deep inspiration breath-hold (DIBH) treatment of left-sided breast cancer.
From February 2017 to July 2019, 135 patients with left-sided breast cancer were selected and prepared for radiotherapy in DIBH. 99 received radiotherapy for the breast alone and 36 for the breast including the lymphatic drainage (RNI). Treatment plans DIBH and free breathing (FB) were calculated. Dosimetrical analyses were performed, and criteria were defined to assess whether a patient would dosimetrically profit from DIBH.
Of the 135 patients, 97 received a DIBH planning CT and 72 were selected for treatment in DIBH according to predefined criteria. When using DIBH, there was a mean reduction of the Dmean of 2.8 Gy and Dmean of 4.2 Gy. seven patients did not benefit from DIBH regarding Dmean, 23 regarding Dmean. For the left lung, the V20Gy was reduced by 4.9%, the V30Gy by 2.7% with 15 and 29 patients not benefiting from DIBH, respectively. In the 25 patients treated in FB, the benefit of DIBH would have been lower than for patients treated with DIBH (ΔDmean0.7 Gy 3.4 Gy).
Dosimetrically, DIBH is no "one-fits-all" approach. However, there is a statistically significant benefit when looking at a larger patient population. DIBH should be used for treatment of left-sided breast cancer in patients fit for DIBH.
This analysis offers a well-designed dosimetrical analysis in patients treated with DIBH radiotherapy in an "every day" cohort.
前瞻性分析用于左侧乳腺癌深吸气屏气(DIBH)治疗的患者准备、治疗计划和选择算法的可行性。
从 2017 年 2 月至 2019 年 7 月,选择 135 例左侧乳腺癌患者接受 DIBH 放射治疗。99 例接受单纯乳房放疗,36 例接受乳房加淋巴引流区(RNI)放疗。计算 DIBH 和自由呼吸(FB)治疗计划。进行剂量学分析,并定义标准以评估患者是否会从 DIBH 中获得剂量学获益。
135 例患者中,97 例接受 DIBH 计划 CT 检查,根据预设标准有 72 例选择 DIBH 治疗。使用 DIBH 时,Dmean 降低 2.8Gy,Dmean 降低 4.2Gy。7 例患者的 Dmean 无获益,23 例患者的 Dmean 无获益。对于左肺,V20Gy 降低 4.9%,V30Gy 降低 2.7%,分别有 15 例和 29 例患者未从 DIBH 中获益。在 25 例接受 FB 治疗的患者中,DIBH 的获益将低于接受 DIBH 治疗的患者(ΔDmean0.7Gy 3.4Gy)。
从剂量学角度来看,DIBH 不是“一刀切”的方法。然而,当观察更大的患者群体时,会有统计学上的显著获益。对于适合 DIBH 的患者,应将 DIBH 用于左侧乳腺癌的治疗。
这项分析为在“日常”队列中接受 DIBH 放疗的患者提供了精心设计的剂量学分析。